A multi-national, $800 billion in assets, institutional lender engaged SCALE to advise in the restructuring of a specialty pharmacy and infusion borrower owned by a private equity firm.
The underlying company included multiple business lines serving both disparate and partially overlapping markets. Each business line had a unique strategic and financial profile, as well as varying levels of reliance on shared corporate infrastructure.
Our client sought to assess various alternatives:
1. Identify strong performing portions of the business and migrate out of weak portions of the business.2. Sale of all or a portion of the business.3. Pursue a partial or full liquidation.4. Pursue an in-court restructuring.
SCALE delivered a detailed assessment report and provided on-going advisory and analytics to support our client’s evaluation of various paths, considerations and potential outcomes.
Elevating healthcare solutions through research and innovation on a global scale.